剂泰科技-P (07666)今日挂牌,公司在香港公开发售录得超6900倍超额认购,锁定认购资金逾7300亿港元,为2026年迄今港股医疗健康IPO香港公开发售认购金额之最,也是年内港股IPO新的“冻资王”;国际配售方面,获得超过208个机构投资人下单,录得可分配额度33.86倍的认购,也是2026年迄今港股医疗健康IPO国际配售认购倍数之最。
根据招股安排,发售价为每股10.50港元,每手500股,一手中签率0.14%。
老虎资讯综合05-13
剂泰科技-P (07666)今日挂牌,公司在香港公开发售录得超6900倍超额认购,锁定认购资金逾7300亿港元,为2026年迄今港股医疗健康IPO香港公开发售认购金额之最,也是年内港股IPO新的“冻资王”;国际配售方面,获得超过208个机构投资人下单,录得可分配额度33.86倍的认购,也是2026年迄今港股医疗健康IPO国际配售认购倍数之最。
根据招股安排,发售价为每股10.50港元,每手500股,一手中签率0.14%。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
